Outpatient cephalosporin use in a Colombian population: prescription-indication study

Misuse of cephalosporins can lead to bacterial resistance. To determine the prescription profile and indication of cephalosporins in the patients affiliated to the Colombian Health System. Cross-sectional study. From a population database, a random sample of patients treated in an outpatient consult...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista chilena de infectología 2021-12, Vol.38 (6), p.737-744
Hauptverfasser: Gaviria-Mendoza, Andrés, Parra-Muñoz, Daniel Alejandro, Sepúlveda-Londoño, Daniel, Gómez-Franco, Juan Sebastián, Salazar-Cuevas, María Camila, Martínez-García, María Paula, Mafla-Ríos, Yuli Vanessa, Machado-Alba, Jorge Enrique
Format: Artikel
Sprache:spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Misuse of cephalosporins can lead to bacterial resistance. To determine the prescription profile and indication of cephalosporins in the patients affiliated to the Colombian Health System. Cross-sectional study. From a population database, a random sample of patients treated in an outpatient consultation was obtained, to identify the indications of the prescribed cephalosporins in their clinical record. Pharmacological variables, and those related to non-indicated formulations were evaluated according to the clinical practice guidelines. In 381 patients, the mean age was 41.2 ± 15.4 years, and 61.4% (n = 234) were women. Cefalexin was the most widely used (n=318; 83.5%), with a mean duration of treatment of 7.3 ± 3.2 days; followed by cefradine (n = 43; 11.3%), and ceftriaxone (n = 20; 5.2%). The most common uses were for skin and soft tissue infections (n = 177; 46.4% of which 47.5% were purulent), urinary tract infections (n = 70; 18.4%), upper respiratory airway infections (n = 57; 15.0%) and sexually transmitted diseases (n = 21; 5.5%). The use was considered indicated in 169 patients (44.4%), but only 103 (60.9%) had prescriptions that met the dosage recommendations from the clinical practice guidelines. More than half of the patients prescribed with cephalosporins in the outpatient setting had prescriptions considered not indicated, particularly for their use in purulent skin and soft tissue infections.
ISSN:0717-6341
DOI:10.4067/s0716-10182021000600737